Wantai Bio to cancel repurchased shares, reducing total capital

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. announced the cancellation of 729,970 repurchased shares from its dedicated securities account. Following this cancellation on December 17, 2025, the company's total share capital will decrease from 1,265,122,774 shares to 1,264,392,804 shares. This move follows a share repurchase program where 1,585,320 shares were bought back by December 21, 2022.

The company initially intended to use the repurchased shares for an employee stock ownership plan or equity incentives. However, after the termination of the 2023 employee stock ownership plan, the company decided to change the purpose of the remaining 729,970 shares to cancellation to reduce registered capital, a decision approved by shareholders on October 31, 2025.

This partial share cancellation is not expected to significantly impact the company's financials, operations, or debt-servicing capabilities, nor will it alter the company's control structure or listing status. The company stated that the shareholding percentage of its controlling shareholder, Yangshengtang Co., Ltd., will passively increase from 73.49% to 73.53% due to the reduction in total share capital.